Cherrystone Angel Group

Cherrystone Angel Group is a prominent angel investment collective based in Providence, Rhode Island, dedicated to fostering the growth of early-stage companies within the vibrant New England ecosystem. Established in 2005, the group comprises accredited investors who pool their capital and expertise to provide crucial seed and early-stage funding. Their strategic focus is primarily on innovative ventures that demonstrate high growth potential and are poised to disrupt their respective industries.

The group's investment thesis is sharply defined, targeting two core sectors: Life Sciences and Technology. Within Life Sciences, Cherrystone actively seeks opportunities across biopharma, medical devices, diagnostics, and digital health, reflecting a commitment to advancements that can significantly impact healthcare. On the technology front, their interests span software, hardware, the Internet of Things (IoT), and advanced materials, indicating a broad yet discerning approach to technological innovation. This dual-sector focus allows them to leverage diverse expertise among their members.

Cherrystone Angel Group typically deploys initial investments ranging from $100,000 to $500,000. This range positions them as a key early-stage capital provider, often serving as the foundational investment that enables startups to achieve critical milestones. The group frequently participates in larger syndicates, collaborating with other angel groups, venture capital firms, and institutional investors to complete more substantial funding rounds. This collaborative approach not only amplifies their impact but also provides their portfolio companies with access to a broader network of resources and follow-on capital. Their long-standing presence since 2005 underscores their consistent commitment to the regional startup community.